Interdisziplinäre AWMF-Leitlinie zur Therapie primärer Antikörpermangelerkrankungen

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Arbeitsgemeinschaft Pädiatrische Immunologie e. V. (API) - (Autor:in)

Abstract

BACKGROUND: Currently, management of antibody deficient patients differs significantly among caregivers. Evidence and consensus based (S3) guidelines for the treatment of primary antibody deficiencies were developed to improve the management of these patients.

METHODS: Based on a thorough analysis of current evidence (systematic literature search in PubMed; deadline November 2011) 14 recommendations were finalized during a consensus meeting in Frankfurt in November 2011 using structured consensus methods (nominal group technique). Experts were nominated by their scientific societies/patient initiatives (Tab. 1).

RESULTS: The guidelines focus on indication, practical issues and monitoring of immunoglobulin replacement therapy as well as on different routes of administration. Furthermore recommendations regarding supportive measures such as antiinfective therapy, vaccinations and physiotherapy are given. Combining literature evidence and experience of caregivers within this evidence and consensus based guidelines offers the chance to improve the quality of care for anti-body deficient patients.

Details

OriginalspracheDeutsch
Seiten (von - bis)404-15
Seitenumfang12
FachzeitschriftKlinische Padiatrie
Jahrgang224
Ausgabenummer6
PublikationsstatusVeröffentlicht - Okt. 2012
Peer-Review-StatusJa

Externe IDs

Scopus 84868502899

Schlagworte

Ziele für nachhaltige Entwicklung

Schlagwörter

  • Adult, Anti-Infective Agents/therapeutic use, Child, Preschool, Combined Modality Therapy, Cooperative Behavior, Evidence-Based Medicine, Humans, Immunization, Passive, Immunologic Deficiency Syndromes/therapy, Interdisciplinary Communication, Physical Therapy Modalities, Quality Improvement, Randomized Controlled Trials as Topic, Vaccination